Fish Oil Derivatives in Hypertriglyceridemia : Mechanism and Cardiovascular Prevention: What Do Studies Say?
Copyright © 2023 Elsevier Inc. All rights reserved..
Hypertriglyceridemia is a type of dyslipidemia characterized by high triglyceride levels in the blood and increases the risk of cardiovascular disease. Conventional management includes antilipidemic medications such as statins, lowering LDL and triglyceride levels as well as raising HDL levels. However, the treatment may be stratified using omega-3 fatty acid supplements such as eicosatetraenoic acid (EPA) and docosahexaenoic acid (DHA), aka fish oil derivatives. Studies have shown that fish oil supplements reduce the risk of cardiovascular diseases; however, the underlying mechanism and the extent of reduction in CVD need more clarification. Our paper aims to review the clinical trials and observational studies in the current literature, investigating the use of fish oil and its benefits on the cardiovascular system as well as the proposed underlying mechanism.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 2023 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Current problems in cardiology - 49(2023), 1 Pt B vom: 01. Jan., Seite 102066 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Erbay, Muhammed Ibrahim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Fatty Acids, Omega-3 |
|---|
| Anmerkungen: |
Date Completed 16.12.2023 Date Revised 16.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cpcardiol.2023.102066 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361552874 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361552874 | ||
| 003 | DE-627 | ||
| 005 | 20231227132946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cpcardiol.2023.102066 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1230.xml |
| 035 | |a (DE-627)NLM361552874 | ||
| 035 | |a (NLM)37657524 | ||
| 035 | |a (PII)S0146-2806(23)00483-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Erbay, Muhammed Ibrahim |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fish Oil Derivatives in Hypertriglyceridemia |b Mechanism and Cardiovascular Prevention: What Do Studies Say? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2023 | ||
| 500 | |a Date Revised 16.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Hypertriglyceridemia is a type of dyslipidemia characterized by high triglyceride levels in the blood and increases the risk of cardiovascular disease. Conventional management includes antilipidemic medications such as statins, lowering LDL and triglyceride levels as well as raising HDL levels. However, the treatment may be stratified using omega-3 fatty acid supplements such as eicosatetraenoic acid (EPA) and docosahexaenoic acid (DHA), aka fish oil derivatives. Studies have shown that fish oil supplements reduce the risk of cardiovascular diseases; however, the underlying mechanism and the extent of reduction in CVD need more clarification. Our paper aims to review the clinical trials and observational studies in the current literature, investigating the use of fish oil and its benefits on the cardiovascular system as well as the proposed underlying mechanism | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Fish Oils |2 NLM | |
| 650 | 7 | |a Fatty Acids, Omega-3 |2 NLM | |
| 650 | 7 | |a Triglycerides |2 NLM | |
| 700 | 1 | |a Gamarra Valverde, Norma Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Parth |e verfasserin |4 aut | |
| 700 | 1 | |a Ozkan, Hasan Selcuk |e verfasserin |4 aut | |
| 700 | 1 | |a Wilson, Andre |e verfasserin |4 aut | |
| 700 | 1 | |a Banerjee, Suvam |e verfasserin |4 aut | |
| 700 | 1 | |a Babazade, Aydan |e verfasserin |4 aut | |
| 700 | 1 | |a Londono, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Sood, Aayushi |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Rahul |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current problems in cardiology |d 1993 |g 49(2023), 1 Pt B vom: 01. Jan., Seite 102066 |w (DE-627)NLM000219622 |x 1535-6280 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2023 |g number:1 Pt B |g day:01 |g month:01 |g pages:102066 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cpcardiol.2023.102066 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2023 |e 1 Pt B |b 01 |c 01 |h 102066 | ||